Clinical Trial Update: Study to Test Safety, Tolerability and Blood Levels of GSK971086 After 1 Dose & 7 Days of Dosing in Healthy Adult Males [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update describes a study to test safety, tolerability, and blood levels of GSK971086 after a single dose and seven days of dosing in he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Androgen Deficiency

Drugs mentioned

• GSK971086

Snippet

Sponsor: GlaxoSmithKline | Conditions: Healthy Subjects, Androgen Deficiency | Phase 1 | Status: COMPLETED